Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action.

In view of the increasing evidence that glucosphingolipids (GSLs) on tumor cell surfaces play an important role in tumor metastasis, an inhibitor of glucosylceramide synthase, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) was used to evaluate the role of GSLs in this respect. Treatment of Lewis lung carcinoma cells with 5 microM D-PDMP resulted in a time-dependent marked decrease in levels of all cellular GSLs (glucosylceramide, lactosylceramide, ceramide trihexoside, globoside, and ganglioside GM3). By 6 days, the total GSL content was reduced to approximately 20% of the level in the untreated control cells and at the same time the lung-colonizing capacity of the PDMP-treated cells in inoculated mice was greatly reduced. Closely associated with the degree of GSL depletion, the ability of the cells to invade reconstituted basement membranes in vitro was also reduced, suggesting that GSLs in tumor cell membranes modulate the cell surface interaction with basement membrane components. In order to assess a possible contribution of the defective capacities to drug-induced suppression of experimental metastasis and invasion, we tested the effect of D-PDMP on attachment and migration to laminin and fibronectin and found that the inhibitor specifically reduced the laminin-mediated attachment and migration, whereas it had no effect on fibronectin-mediated attachment and migration. These effects of the inhibitor on lung colonizing capacity in vivo and the invasion, adhesion, and migration properties of the cells in vitro were reversible within 24 h after removal of the drug. By contrast, L-PDMP (the enantiomeric form of D-PDMP), which has no inhibitory activity on glucosylceramide synthesis, did not cause any of the changes produced by D-PDMP. Together, these results suggest that GSLs in tumor cell membranes are essential for the metastatic spread of tumor cells through basement membranes, modulating the interaction of laminin and its receptors.

[1]  H. Kleinman,et al.  Identification of an amino acid sequence in the laminin A chain mediating mast cell attachment and spreading. , 1991, Immunology.

[2]  N. Radin,et al.  Glucosphingolipid dependence of hormone-stimulated inositol trisphosphate formation. , 1990, The Journal of biological chemistry.

[3]  K. Handa,et al.  A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis. , 1990, Biochemistry.

[4]  N. Radin,et al.  Effects of D‐threo‐PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells , 1989, Journal of cellular physiology.

[5]  H. Kleinman,et al.  Identification of a second active site in laminin for promotion of cell adhesion and migration and inhibition of in vivo melanoma lung colonization. , 1989, Archives of biochemistry and biophysics.

[6]  S. Hakomori,et al.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. , 1988, The Journal of biological chemistry.

[7]  N. Radin,et al.  Glucosphingolipids as sites of action in the chemotherapy of cancer. , 1988, Biochemical pharmacology.

[8]  S. Hakomori,et al.  Phenotypic changes in 3T3 cells associated with the change of sphingolipid synthesis by a ceramide analog, 2‐decanoylamino‐3‐morpholino‐1‐phenylpropanol (compound RV538) , 1988, FEBS letters.

[9]  L. Liotta,et al.  Laminin-dependent and laminin-independent adhesion of human melanoma cells to sulfatides. , 1988, Cancer research.

[10]  U. Chattopadhyay,et al.  Changes in plasma gangliosides in relation to tumor growth and their tumor‐enhancing effect , 1988, International journal of cancer.

[11]  B. Zetter,et al.  Lewis lung carcinoma variants with differing metastatic specificities adhere preferentially to different defined extracellular matrix molecules. , 1988, Invasion & metastasis.

[12]  N. Radin,et al.  Antitumor activity via inhibition of glycosphingolipid biosynthesis. , 1987, Cancer letters.

[13]  H. Kleinman,et al.  YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. , 1987, Science.

[14]  P. Gullino,et al.  Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. , 1987, Cancer research.

[15]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[16]  N. Radin,et al.  Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase. , 1987, Journal of lipid research.

[17]  W. Curatolo,et al.  Glycolipid function. , 1987, Biochimica et biophysica acta.

[18]  A. Dell,et al.  Glycosphingolipids of lectin-resistant mutants of the highly metastatic mouse tumor cell line, MDAY-D2. , 1987, Cancer research.

[19]  D. Cheresh,et al.  Disialoganglioside GD2 distributes preferentially into substrate- associated microprocesses on human melanoma cells during their attachment to fibronectin , 1986, The Journal of cell biology.

[20]  K. Mujoo,et al.  Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins , 1986, The Journal of cell biology.

[21]  L. Liotta,et al.  Biochemical interactions of tumor cells with the basement membrane. , 1986, Annual review of biochemistry.

[22]  L. Liotta.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.

[23]  J. Schlessinger,et al.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. , 1986, The Journal of biological chemistry.

[24]  P. Mühlradt,et al.  Glycoconjugates of murine tumor lines with different metastatic capacities. II. Diversity of glycolipid composition , 1985, International journal of cancer.

[25]  S. Hakomori,et al.  Inhibition of tumor cell growth by aggregation of a tumor-associated glycolipid antigen: a close functional association between gangliotriaosylceramide and transferrin receptor in mouse lymphoma L-5178Y. , 1985, Cancer research.

[26]  S. Hakomori,et al.  Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. , 1985, Cancer research.

[27]  D. Cheresh.  Structural and functional properties of ganglioside antigens on human tumors of neuroectodermal origin. , 1985, Survey and synthesis of pathology research.

[28]  Liotta La.  Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. , 1984, The American journal of pathology.

[29]  L. Liotta,et al.  Laminin molecular domains which alter metastasis in a murine model. , 1984, The Journal of clinical investigation.

[30]  D. Cheresh,et al.  Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Wicha,et al.  Metastatic potential of murine fibrosarcoma cells is influenced by cell surface laminin , 1984, International journal of cancer.

[32]  L. Liotta.  Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. , 1984, The American journal of pathology.

[33]  C. C. Blackburn,et al.  Carbohydrate-specific cell adhesion is mediated by immobilized glycolipids. , 1983, The Journal of biological chemistry.

[34]  L. Liotta,et al.  Role of laminin in the attachment and metastasis of murine tumor cells. , 1982, Cancer research.

[35]  F. Podlaski,et al.  Ganglioside profiles of metastases and of metastasizing and nonmetastasizing rat primary mammary carcinomas. , 1981, Journal of the National Cancer Institute.

[36]  S. Hakomori,et al.  Selective inhibition of cell growth and associated changes in glycolipid metabolism induced by monovalent antibodies to glycolipids. , 1977, Experimental cell research.

[37]  M. Sudo.  Brain glycolipids in infantile Gaucher's disease , 1977, Journal of neurochemistry.

[38]  H. Wexler.  Accurate identification of experimental pulmonary metastases. , 1966, Journal of the National Cancer Institute.